Compare HSTM & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HSTM | PRME |
|---|---|---|
| Founded | 1990 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 700.0M | 666.1M |
| IPO Year | 1999 | 2022 |
| Metric | HSTM | PRME |
|---|---|---|
| Price | $22.57 | $2.98 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $28.00 | $7.56 |
| AVG Volume (30 Days) | 193.6K | ★ 2.0M |
| Earning Date | 05-04-2026 | 05-08-2026 |
| Dividend Yield | ★ 0.66% | N/A |
| EPS Growth | N/A | ★ 18.18 |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $304,064,000.00 | $4,632,000.00 |
| Revenue This Year | $9.45 | $7.06 |
| Revenue Next Year | $5.12 | $47.01 |
| P/E Ratio | $113.77 | ★ N/A |
| Revenue Growth | 4.26 | ★ 55.28 |
| 52 Week Low | $19.50 | $1.11 |
| 52 Week High | $29.59 | $6.94 |
| Indicator | HSTM | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 53.52 | 32.81 |
| Support Level | $21.19 | N/A |
| Resistance Level | $24.17 | $3.97 |
| Average True Range (ATR) | 0.97 | 0.24 |
| MACD | 0.03 | -0.05 |
| Stochastic Oscillator | 53.69 | 5.20 |
HealthStream Inc provides SaaS based applications for healthcare organizations all designed to improve business and clinical outcomes by supporting the people who deliver patient care. The company is focused on helping individuals and organizations in healthcare meet their ongoing learning, clinical development, credentialing, and scheduling needs. It also provides its solutions to nursing schools and nursing students.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.